When genetic testing matters beyond treatment: why not all personal utility is equal

By Dr Johnny Sakr Genetic testing is often assessed by asking a familiar question: does it change clinical management? If the answer is yes, the value of the test is relatively easy to explain. It may guide treatment, avoid unnecessary investigations, or improve health outcomes. But many genomic tests produce information that families value even […]

Read More…

Variants of unknown significance in stem cell donation – new dilemmas in genomic practice

By Helena Carley, Kate Sahan, Helen Hanson, Katie Snape, Sarah Westbury, Michael J Parker, & Anneke M Lucassen Current popular discourse surrounding genomics is frequently one of ‘clarity’ and ‘transformation’, concepts projected by the NHS 10 year plan and echoed in the media. Technological advances in genomics over recent years have been impressive: whole genome […]

Read More…

We don’t know if the babies born from mitochondrial replacement therapy will still develop mitochondrial disease

By Katherine Drabiak Recently, media outlets around the world have been reporting on children born from pronuclear genome transfer (sometimes called “3-parent IVF,” “mitochondrial donation” or “mitochondrial replacement therapy”) at Newcastle Fertility Center in the United Kingdom. Twenty-two women underwent the procedure, which resulted in eight children, who now range in age from six months to over two […]

Read More…

If Marc is Suzanne’s father, does it follow that Suzanne is his child?

By Daniela Cutas, Anna Smajdor, Kristien Hens, and Emma Moormann According to the respondents in our study, the short answer is: not necessarily. We drafted a series of vignettes in which we explored the relationships between reproduction, genes, and parenthood. We wanted to understand the impact that the degree of genetic relatedness might have on […]

Read More…

Genetic research and the collective good: participants as leaders

By Ilaria Galasso and Susi Geiger. Medical ethics has long centered around the question of how to balance the public or common good with individual rights. Different approaches to ethics would prioritize different values in the context of medical research participation. Well-established moral principles provide solid arguments both for an obligation to participate in medical […]

Read More…

Developing a practical resource to improve the ethical standing of gene therapy trials

By Rosie Munday, Hugh Davies and Stephanie Jones with Oxford “A” Health Research Authority Research Ethics Committee Oxford “A” NHS REC is one of the four UK Research Ethics Committees flagged to review gene therapy proposals. Following the philosopher Mary Warnock’s sage advice “I do not believe you can make moral judgements unless, as far […]

Read More…